0001209191-21-003254.txt : 20210112 0001209191-21-003254.hdr.sgml : 20210112 20210112164926 ACCESSION NUMBER: 0001209191-21-003254 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210108 FILED AS OF DATE: 20210112 DATE AS OF CHANGE: 20210112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THOMAS FRANK E CENTRAL INDEX KEY: 0001242616 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38722 FILM NUMBER: 21524026 MAIL ADDRESS: STREET 1: C/O ORCHARD THERAPEUTICS STREET 2: 101 SEAPORT BOULEVARD, 7TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Orchard Therapeutics plc CENTRAL INDEX KEY: 0001748907 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 108 CANNON STREET CITY: LONDON STATE: X0 ZIP: EC4N 6EU BUSINESS PHONE: 011-44-0-203-3846700 MAIL ADDRESS: STREET 1: 108 CANNON STREET CITY: LONDON STATE: X0 ZIP: EC4N 6EU FORMER COMPANY: FORMER CONFORMED NAME: Orchard Rx Ltd DATE OF NAME CHANGE: 20180802 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-08 0 0001748907 Orchard Therapeutics plc ORTX 0001242616 THOMAS FRANK E C/O ORCHARD THERAPEUTICS PLC 108 CANNON STREET LONDON X0 EC4N 6EU UNITED KINGDOM 0 1 0 0 See Remarks Ordinary Shares 2021-01-08 4 A 0 10667 0.00 A 35787 D Ordinary Shares 2021-01-11 4 F 0 3706 6.72 D 32081 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. On January 16, 2019, the Reporting Person was granted certain performance-based Restricted Share Units ("RSUs"), the vesting of which was subject to the achievement of certain performance criteria. As of the transaction date, the first of three performance criteria was met, resulting in the vesting of 10,667 RSUs. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. Title: President & Chief Operating Officer /s/ Frank Thomas 2021-01-12